Mr. Shane Johnson - 19 Dec 2025 Form 4 Insider Report for InMed Pharmaceuticals Inc. (INM)

Role
Sr VP & General Manager
Signature
/s/ Eric A Adams, attorney-in-fact for Mr. Shane Johnson
Issuer symbol
INM
Transactions as of
19 Dec 2025
Net transactions value
$0
Form type
4
Filing time
19 Dec 2025, 11:42:54 UTC
Previous filing
23 Dec 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Johnson Shane Aaron Sr VP & General Manager C/O INMED PHARMACEUTICALS INC., 1445-885 WEST GEORGIA ST., VANCOUVER, BRITISH COLUMBIA, CANADA /s/ Eric A Adams, attorney-in-fact for Mr. Shane Johnson 19 Dec 2025 0001889332

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INM Employee Stock Option (Right to Buy) Award $0 +8,500 +218% $0.000000 12,400 19 Dec 2025 Common shares 8,500 $1.29 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on 12/19/2025 and will vest in equal installments monthly, in arrears, over 36 months (1/36 per month)